These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39186982)

  • 21. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
    Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
    Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species.
    Kang SU; Cho JH; Chang JW; Shin YS; Kim KI; Park JK; Yang SS; Lee JS; Moon E; Lee K; Kim CH
    Cell Death Dis; 2014 Feb; 5(2):e1056. PubMed ID: 24525732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.
    Guan L; Nambiar DK; Cao H; Viswanathan V; Kwok S; Hui AB; Hou Y; Hildebrand R; von Eyben R; Holmes BJ; Zhao J; Kong CS; Wamsley N; Zhang W; Major MB; Seol SW; Sunwoo JB; Hayes DN; Diehn M; Le QT
    Cancer Res; 2023 Mar; 83(6):861-874. PubMed ID: 36652552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death.
    Allevato MM; Trinh S; Koshizuka K; Nachmanson D; Nguyen TC; Yokoyama Y; Wu X; Andres A; Wang Z; Watrous J; Molinolo AA; Mali P; Harismendy O; Jain M; Wild R; Gutkind JS
    Cancer Lett; 2024 Aug; 598():217089. PubMed ID: 38964731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.
    Sano D; Matsumoto F; Valdecanas DR; Zhao M; Molkentine DP; Takahashi Y; Hanna EY; Papadimitrakopoulou V; Heymach J; Milas L; Myers JN
    Clin Cancer Res; 2011 Apr; 17(7):1815-27. PubMed ID: 21350000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
    Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
    Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB‑EGF.
    Fu E; Liu T; Yu S; Chen X; Song L; Lou H; Ma F; Zhang S; Hussain S; Guo J; Sun J; Yu P; Mao X; Wei L
    Oncol Rep; 2020 Aug; 44(2):698-710. PubMed ID: 32627036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities.
    Bonner JA; Maihle NJ; Folven BR; Christianson TJ; Spain K
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):243-7. PubMed ID: 8195014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status.
    Sandulache VC; Skinner HD; Ow TJ; Zhang A; Xia X; Luchak JM; Wong LJ; Pickering CR; Zhou G; Myers JN
    Cancer; 2012 Feb; 118(3):711-21. PubMed ID: 21720999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual gammaH2AX foci in head and neck squamous cell carcinomas as predictors for tumour radiosensitivity: Evaluation in pre-clinical xenograft models and clinical specimens.
    Meneceur S; Löck S; Gudziol V; Hering S; Bütof R; Rehm M; Baumann M; Krause M; von Neubeck C
    Radiother Oncol; 2019 Aug; 137():24-31. PubMed ID: 31048234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition.
    Eke I; Dickreuter E; Cordes N
    Radiother Oncol; 2012 Aug; 104(2):235-42. PubMed ID: 22748391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-7-5p Is Involved in Ferroptosis Signaling and Radioresistance Thru the Generation of ROS in Radioresistant HeLa and SAS Cell Lines.
    Tomita K; Nagasawa T; Kuwahara Y; Torii S; Igarashi K; Roudkenar MH; Roushandeh AM; Kurimasa A; Sato T
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells.
    Wang XW; Yang ZY; Li T; Zhao XR; Li XZ; Wang XX
    Mol Biotechnol; 2024 Sep; 66(9):2558-2568. PubMed ID: 37751128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
    Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
    Alhazzazi TY; Kamarajan P; Xu Y; Ai T; Chen L; Verdin E; Kapila YL
    Anticancer Res; 2016 Jan; 36(1):49-60. PubMed ID: 26722027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
    Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
    Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
    Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK
    Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.